Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.

Cancer - 15 Nov 2017

Nguyen Kevin A, Syed Jamil S, Espenschied Carin R, LaDuca Holly, Bhagat Ansh M, Suarez-Sarmiento Alfredo, O'Rourke Timothy K, Brierley Karina L, Hofstatter Erin W, Shuch Brian

Abstract excerpt

BACKGROUND: Panel testing has been recently introduced to evaluate hereditary cancer; however, limited information is available regarding its use in kidney cancer. METHODS: The authors retrospectively reviewed test results and clinical data from patients who underwent targeted multigene panel testing of up to 19 genes associated with hereditary kidney cancer from 2013 to 2016. The frequency of positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Neoplastic Syndromes, Hereditary

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins

Share to Transcriptome

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 28787086
DOI: 10.1002/cncr.30893

Genes

FLCN
MET
MITF
PMS1
PMS2
TSC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.PMID 28787086Read ↗

Inherited kidney cancer syndromesSemantic proximity Read ↗

Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups.Semantic proximity Read ↗

Renal Cell Cancer Syndromes: Identification and Management of Patients and Families at Increased Risk.Semantic proximity Read ↗

Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.Semantic proximity Read ↗

Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic.Semantic proximity Read ↗

Molecular diagnostic results of a nephropathy gene panel in patients with suspected hereditary kidney disease.Semantic proximity Read ↗

Clinical utility of genetic and genomic testing in the precision diagnosis and management of pediatric patients with kidney and urinary tract diseasesSemantic proximity Read ↗

Canadian guideline on genetic screening for hereditary renal cell cancersSemantic proximity Read ↗

Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017.Semantic proximity Read ↗

Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.Semantic proximity Read ↗

A step-by-step, multidisciplinary strategy to maximize the yield of genetic testing in pediatric patients with chronic kidney diseases.Semantic proximity Read ↗

Genetic predisposition to kidney cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.